Melvin Spigelman
Directeur/Membre du Conseil chez AN2 THERAPEUTICS, INC.
Fortune : - $ au 30/04/2024
Postes actifs de Melvin Spigelman
Sociétés | Poste | Début | Fin |
---|---|---|---|
AN2 THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/02/2022 | - |
Independent Dir/Board Member | 01/02/2022 | 16/03/2022 | |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Directeur/Membre du Conseil | 01/06/2003 | - |
Directeur Général | 01/01/2009 | - | |
President | 01/01/2009 | - | |
Directeur Technique/Scientifique/R&D | 01/06/2003 | 01/01/2009 | |
Wellington Partners GmbH
Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Private Equity Investor | 01/01/2005 | - |
Tres Cantos Open Lab Foundation
Tres Cantos Open Lab Foundation Miscellaneous Commercial ServicesCommercial Services Tres Cantos Open Lab Foundation provides research facilities for charity. The non-profit company is based in Guildford, UK. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Melvin Spigelman
Anciens postes connus de Melvin Spigelman
Sociétés | Poste | Début | Fin |
---|---|---|---|
SYNERGY PHARMACEUTICALS INC | Directeur/Membre du Conseil | 21/08/2008 | 31/10/2018 |
Président | 31/10/2018 | 01/05/2019 | |
Independent Dir/Board Member | 21/08/2008 | 31/10/2018 | |
THE MEDICINES COMPANY | Directeur/Membre du Conseil | 27/09/2005 | 01/01/2018 |
Independent Dir/Board Member | 27/09/2005 | 01/01/2018 | |
Hudson-Douglas Ltd. | President | - | 01/06/2003 |
ABBOTT INDIA LIMITED | Directeur Technique/Scientifique/R&D | 01/01/1992 | 01/01/2000 |
Corporate Officer/Principal | 01/01/2000 | 01/01/2001 | |
Knoll Pharmaceutical Co. | Directeur Technique/Scientifique/R&D | 01/01/1992 | 01/01/2000 |
Corporate Officer/Principal | 01/01/2000 | 01/01/2001 | |
░░░░░ ░░░░░░ ░░ ░░░░░░░░ ░░ ░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formation de Melvin Spigelman
Brown University | Undergraduate Degree |
Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 9 |
Inde | 2 |
Allemagne | 2 |
Opérationnelle
Director/Board Member | 5 |
Chief Tech/Sci/R&D Officer | 3 |
Independent Dir/Board Member | 3 |
Sectorielle
Health Technology | 6 |
Consumer Services | 3 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
ABBOTT INDIA LIMITED | Health Technology |
AN2 THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 7 |
---|---|
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Health Technology |
Synergy Pharmaceuticals LLC
Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
Hudson-Douglas Ltd. | |
The Medicines Co.
The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Wellington Partners GmbH
Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Finance |
Tres Cantos Open Lab Foundation
Tres Cantos Open Lab Foundation Miscellaneous Commercial ServicesCommercial Services Tres Cantos Open Lab Foundation provides research facilities for charity. The non-profit company is based in Guildford, UK. | Commercial Services |
Knoll Pharmaceutical Co. |
- Bourse
- Insiders
- Melvin Spigelman
- Expérience